TW200417595A - Composition containing organic substance having double bond with improved oxidation stability - Google Patents
Composition containing organic substance having double bond with improved oxidation stability Download PDFInfo
- Publication number
- TW200417595A TW200417595A TW092132690A TW92132690A TW200417595A TW 200417595 A TW200417595 A TW 200417595A TW 092132690 A TW092132690 A TW 092132690A TW 92132690 A TW92132690 A TW 92132690A TW 200417595 A TW200417595 A TW 200417595A
- Authority
- TW
- Taiwan
- Prior art keywords
- patent application
- scope
- sesame
- item
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 239000000126 substance Substances 0.000 title claims abstract description 27
- 230000003647 oxidation Effects 0.000 title abstract description 49
- 238000007254 oxidation reaction Methods 0.000 title abstract description 49
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 98
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 83
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 83
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 81
- 241000207961 Sesamum Species 0.000 claims abstract description 76
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 59
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 57
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 57
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 55
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 50
- 235000021323 fish oil Nutrition 0.000 claims abstract description 49
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 49
- -1 ascorbic acid fatty acid ester Chemical class 0.000 claims abstract description 43
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 39
- 229930195729 fatty acid Natural products 0.000 claims abstract description 39
- 239000000194 fatty acid Substances 0.000 claims abstract description 39
- 235000013305 food Nutrition 0.000 claims abstract description 23
- 239000000470 constituent Substances 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 63
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 48
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 48
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 47
- 229940046009 vitamin E Drugs 0.000 claims description 39
- 239000011709 vitamin E Substances 0.000 claims description 39
- 235000019197 fats Nutrition 0.000 claims description 33
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 32
- 239000013589 supplement Substances 0.000 claims description 30
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 claims description 29
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 claims description 29
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 17
- 229930003427 Vitamin E Natural products 0.000 claims description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 16
- 235000019165 vitamin E Nutrition 0.000 claims description 16
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000008159 sesame oil Substances 0.000 claims description 15
- 235000011803 sesame oil Nutrition 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 13
- 150000004665 fatty acids Chemical class 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 11
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 10
- 150000002632 lipids Chemical class 0.000 claims description 10
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 9
- HGXBRUKMWQGOIE-WZBLMQSHSA-N epipinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-WZBLMQSHSA-N 0.000 claims description 9
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 7
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 7
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 7
- 235000013350 formula milk Nutrition 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 claims description 5
- 235000007221 pinoresinol Nutrition 0.000 claims description 5
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 3
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 claims description 3
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004261 Ascorbyl stearate Substances 0.000 claims description 2
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 claims description 2
- 235000004338 Syringa vulgaris Nutrition 0.000 claims description 2
- 244000297179 Syringa vulgaris Species 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 235000019276 ascorbyl stearate Nutrition 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 2
- 239000005416 organic matter Substances 0.000 claims description 2
- 235000001497 healthy food Nutrition 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 abstract description 51
- 239000003814 drug Substances 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000011368 organic material Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 52
- 239000003925 fat Substances 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- 230000000694 effects Effects 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 24
- 239000001301 oxygen Substances 0.000 description 24
- 229910052760 oxygen Inorganic materials 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 238000010521 absorption reaction Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 11
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 8
- 235000014593 oils and fats Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 235000019512 sardine Nutrition 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 241001125048 Sardina Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 244000000231 Sesamum indicum Species 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 229940074391 gallic acid Drugs 0.000 description 5
- 235000004515 gallic acid Nutrition 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000010775 animal oil Substances 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 4
- 235000010350 erythorbic acid Nutrition 0.000 description 4
- 239000004318 erythorbic acid Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 229940026239 isoascorbic acid Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 229940072107 ascorbate Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 241001233037 catfish Species 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000001877 deodorizing effect Effects 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000002310 Isopropyl citrate Substances 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- SKHXHUZZFVMERR-UHFFFAOYSA-L isopropyl citrate Chemical compound CC(C)OC(=O)CC(O)(C([O-])=O)CC([O-])=O SKHXHUZZFVMERR-UHFFFAOYSA-L 0.000 description 2
- 235000019300 isopropyl citrate Nutrition 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 229960003951 masoprocol Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 229940116257 pepper extract Drugs 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- WEMBXHSHIVWJOF-UHFFFAOYSA-N (2-methylphenyl)-phenylmethanediol Chemical compound CC1=C(C=CC=C1)C(O)(O)C1=CC=CC=C1 WEMBXHSHIVWJOF-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- DTCCTIQRPGSLPT-ONEGZZNKSA-N (E)-2-pentenal Chemical compound CC\C=C\C=O DTCCTIQRPGSLPT-ONEGZZNKSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- CIWBSHSKHKDKBQ-SZSCBOSDSA-N 2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound OC[C@H](O)C1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-SZSCBOSDSA-N 0.000 description 1
- NIONDZDPPYHYKY-UHFFFAOYSA-N 2-hexenoic acid Chemical compound CCCC=CC(O)=O NIONDZDPPYHYKY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241000723185 Cyathea Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 229930182474 N-glycoside Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 240000008474 Pimenta dioica Species 0.000 description 1
- 235000006990 Pimenta dioica Nutrition 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- DRUQKRWRXOUEGS-NGERZBJRSA-N Samin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3O)=C1 DRUQKRWRXOUEGS-NGERZBJRSA-N 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- REOLHJDOUUORKY-UHFFFAOYSA-J [Na+].[Na+].[Ca+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O Chemical compound [Na+].[Na+].[Ca+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O REOLHJDOUUORKY-UHFFFAOYSA-J 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 238000011276 addition treatment Methods 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940070316 aspergillus terreus extract Drugs 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- DTCCTIQRPGSLPT-UHFFFAOYSA-N beta-Aethyl-acrolein Natural products CCC=CC=O DTCCTIQRPGSLPT-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- HJSJHFXDUMCZEC-UHFFFAOYSA-N dichloroarsenic Chemical compound Cl[As]Cl HJSJHFXDUMCZEC-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 229940066279 eicosapentaenoate Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- ITNKVODZACVXDS-YATCGRJWSA-N ethyl (4e,7e,10e,13e,16e,19e)-docosa-4,7,10,13,16,19-hexaenoate Chemical compound CCOC(=O)CC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CC ITNKVODZACVXDS-YATCGRJWSA-N 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002341 glycosylamines Chemical class 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002600 icosapent ethyl Drugs 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229920003049 isoprene rubber Polymers 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960001730 nitrous oxide Drugs 0.000 description 1
- 235000013842 nitrous oxide Nutrition 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 108010088896 rutinase Proteins 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012747 synergistic agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 229960002415 trichloroethylene Drugs 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/34—Anti-oxidant compositions; Compositions inhibiting chemical change containing plant or animal materials of unknown composition
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
- C11B5/0028—Carboxylic acids; Their derivates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Cosmetics (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicinal Preparation (AREA)
Description
200417595 玖、發明說明: 【發明所屬之技術領域】 本發明係關於含有具經提高氧化安定性之雙鍵的有 物之組成物。詳細言之,係對具有高度不飽和脂肪酸之 的容易氧化之雙鍵的有機物添加入作為抗氧化劑之芝麻 抗氧化成分及抗壞血酸或抗壞血酸脂肪酸酯,所成之氧 安定性經提高的組成物。 本發明中,高度不飽和脂肪酸係指具有3個以上的雙 之脂肪酸。 【先前技術】 近年來,油脂類(尤其是含有高度不飽和脂肪酸的油 類)具有生理上的作用之情事曰漸廣為人知,基於健康 向,作為食品與飼料之添加用等而曰漸受到廣泛的利用 二十碳五烯酸及二十二碳六烯酸係主要含有於魚油中之 度不飽和脂肪酸,其等經發現具有對高血脂症、高血壓 預防、皮膚的老化防止等之各種作用,作為用以增進健 的食品材料、醫藥品而被利用。然而,由於含有高度不 和脂肪酸的油脂類之氧化安定性低,故不僅可添加的食 有限制,且於添加到食品等之時,因其製造過程中之些 的氧化也會產生味道,是其問題所在。必須於使用後殘 的精製魚油的罐中封入氮氣並加以密閉等,並就油脂的 用之本身予以考量,而且其使用,例如製品的種類、流 溫度、添加量等本身即有所限制。 例如,由於二十二碳六烯酸與二十碳五烯酸,對於幼 312/發明說明書(補件)/93-02/92132690 機 類 的 化 鍵 脂 指 〇 高 的 康 飽 品 微 存 取 通 兒 5 200417595 的腦與視網膜的發展與記憶學習能力有重要的作用,在母 乳中含有著此等脂肪酸,故育嬰用調製乳中添加有含有二 十二碳六烯酸、二十碳五烯酸的魚油而販售於市面。又, 由於花生酸於發育上有著重要的作用,並含有於母乳中, 故於育嬰用調製乳中亦嘗試著添加花生酸。然而,於將此 等高度不飽和脂肪酸調配於育嬰用調製乳中時,若對高度 不飽和脂肪酸的氧化不加以注意,會產生因氧化所造成的 氧化臭味,故會發生不易攝取,或調製乳本身也會變質, 甚而有發生有毒化的情形。 二十碳五烯酸乙酯有作成為膠囊製劑作為口服藥品而 販售著。又,含有二十碳五烯酸、二十二碳六烯酸之精製 魚油之膠囊製劑亦作為健康食品而販售著。由於易於氧 化,故甚少被用於膠囊製劑以外的用途。 此等油脂之氧化安定性的提高的形態之一為粉末化,為 了得到安定的油脂粉末,採用將油脂封入微膠囊中進行粉 末化,或用環狀糊精將油脂包住進行粉末化的方法等。然 而,該等之製造作業繁雜且生產性差,且於保存中等會發 生膠囊損壞之情事,故可作為食品、飼料等使用的膠囊之 種類有其限制等,是問題點所在。 又,過去為提高油脂的氧化安定性,使用抗氧化劑。該 情形下,經由組合複數的抗氧化劑,或經由添加抗氧化劑 與磷酸、擰檬酸、抗壞血酸之類的相乘劑(s y n e r g i s t)以提 高抗氧化性,已廣為人知。然而,於如同魚油般的氧化安 定性非常低的油脂的情況,若只靠一般所考量的抗氧化劑 6 312/發明說明書(補件)/93-02/92132690 200417595 與相乘劑的組合,氧化安定性的提高有其限度。 為防止油脂的氧化,作為氧化防止劑經認可使用於含有 油脂類及油脂的食品用者有··二丁基羥基甲苯(Β Η T )、丁基 羥基茴香醚(Β Η A )、五倍子酸、五倍子酸丙酯、維生素 Ε 類等。於醫藥品等中,作為合成抗氧化劑則使用Β Η T、Β Η A、 TBHQ、乙氧嗜(ethoxyquin)等。 由於芝麻油對於氧化比較安定,芝麻中含有抗氧化成分 自古即為人所知,而其含有芝麻紛(sesamol)等之木齡素 (1 i g n a η )亦為人所知(日本專利特開昭 5 8 - 1 3 2 0 7 6 號公 報;食的科學,225(11)ρ·40-48(1996);同雜誌,225(11) ρ· 32-36(1996)) ° 芝麻酴為經認可作為食品添加物之用於含有油脂類及 油脂的食品用氧化防止劑,但根據報告,其對於如魚油般 的氧化安定性極差的油脂並無效果(日本油脂(股),DHA高 度精製萃取技術開發事業平成4-8年度結果概要(DHA高度 精製萃取技術研究團隊)ρ74-79(2002)),而無法使用來提 高魚油的氧化安定性。 又,抗壞血酸或抗壞血酸衍生物雖為經認可作為食品添 加物之使用於含有油脂類及油脂的食品用之氧化防止劑, 但對於如魚油般的氧化安定性極差的油脂,其單獨使用並 無效果,即使與維生素Ε組合使用,效果亦不理想。 為了油脂的氧化防止,曾嘗試組合各種抗氧化劑而使 用。例如,於日本專利特開2 0 0 2 - 1 4 2 6 7 3號公報中記述著 將五倍子酸、水溶性抗氧化劑及油溶性抗氧化劑以親油性 7 312/發明說明書(補件)/93-02/92132690 200417595 乳化劑乳化成油中水型而作成的親油性氧化防止劑。作為 水溶性抗氧化劑,例示有:維生素 c、檸檬酸、漂木酸及 其衍生物、糖胺基反應物、前花青素 (proanthocyanidine)、黃酮(flavone)衍生物、茶萃取物、 葡萄子萃取物及芸香苷;又,作為油溶性抗氧化劑,則例 示有:維生素E、抗壞血酸棕櫚酸酯、芝麻酚、7 -谷維醇 (r-oryzanol) 〇 於曰本營養·食糧學會誌,44(6) p.493-498(1991); 同雜誌 45(3) p. 291-295(1992);同雜誌 45(3) p . 2 8 5 - 2 9 0 ( 1 9 9 2 )中,曾就植物油脂中的維生素E的熱分解 之各種抗氧化劑的效果做了比較檢討。於該等各種抗氧化 劑中,雖亦含有芝麻酚與抗壞血酸酯併用者,但與其他的 抗氧化劑比較並未見有特別優異的效果。吾人認為,該文 獻中並非以高度不飽和脂肪酸(不飽和鍵為3個以上)之於 室溫等保存時所發生的氧化為對象,而係以植物油(不飽和 鍵為 3個以下)之高溫加熱時的油脂之氧化中的效果為對 象,由於對象物或條件不同,故未能發現芝麻酚與抗壞血 酸酯的併用所達成之優異的效果。又,吾人認為抗氧化劑 本身的熱安定性亦有影響。 目前,於含有不飽和脂肪酸的油脂類的需要日益增高, 而包含其取用性之氧化安定性的問題須慎重地加以解決乙 事則受到殷切的期盼。 【發明内容】 本發明以提供含有具經大幅提高氧化安定性之雙鍵的 8 312/發明說明_ 補件)/93-02/92132690 200417595 有機物,尤其是提供高度不飽和脂肪酸或其酯為課題。 本發明者等,針對提高油脂(含有大量的高度不飽和脂 肪酸的油脂,例如魚油等之水產動物油)的氧化安定性進行 反覆檢討之結果,發現:藉由添加芝麻酚與抗壞血酸或抗 壞血酸脂肪酸酯之組合,油脂的氧化安定性可大幅地提 高。再者,藉由芝麻酚以外的芝麻的抗氧化成分與抗壞血 酸或抗壞血酸脂肪酸酯之組合,亦可大幅提高抗氧化作 用,本發明於焉得以完成。 本發明之要旨在於下述(1 )〜(1 3 )中所記述之組成物。 (1 )添加有作為抗氧化劑之芝麻的抗氧化成分及抗壞血 酸或抗壞血酸脂肪酸酯的含有具氧化安定性之雙鍵之有機 物的組成物。 (2)雙鍵為具有活性亞甲基(methylene)的雙鍵或末端 的雙鍵之(1 )的含有具有雙鍵之有機物的組成物。 (3 )具有雙鍵之有機物為高度不飽和脂肪酸、其鹽、或 其酯之(1 )的組成物。 (4 )高度不飽和脂肪酸為含有二十碳五烯酸、二十二碳 六烯酸之任一者1種以上的脂肪酸之(3 )的組成物。 (5 )高度不飽和脂肪酸的酯為含有以高度不飽和脂肪酸 作為構成成分之三酸甘油酯或高度不飽和脂肪酸的低級醇 酯之(3 )或(4 )的組成物。 (6 )含有作為精製魚油之高度不飽和脂肪酸的酯之(3 ) 或(4 )的組成物。 (7 )芝麻的抗氧化成分係含有可經由使用電化學檢測器 9 312/發明說明書(補件)/93-02/92132690 200417595 之高效液相層析儀(Η P L C )檢測之溶出時間在2 . 6 6、3 . 4 0、 3.84、 4.57、 4.98、 5.82、 7.00、 8.67、 9.84、 11.24、 12.29、 12.49、 13.36、 14.04、 14.32、 14.74、 15.22、 15.60、 15.82、 16.34、16.98、18.10、18.43、3 4 · 9 1 分附近顯示出波峰 的成分之至少一個以上的(1 )至(6 )中任一者之組成物。 (8 )芝麻的抗氧化成分為芝麻、芝麻油或芝麻〉查之錯由 溶劑、脂質、或乳化劑之任一者的單獨或混合溶劑之萃取 物之(1 )至(6 )中任一者之組成物。 (9 )芝麻的抗氧化成分為含有選自芝麻酚、芝麻明酚 (sesaminol )、 表芝麻明酉分(episesaminol)、 松月旨西享 (pinoresinol)、表松月旨醇(epi-pinoresinol)、紫 丁香樹 月旨酉分(syringaresinol)、 沙敏 (samin)、 芝麻林盼 (sesamorinol) 、 2,3-二(4,-經基一3,_甲氧亨基)一2 -丁稀 -4 -經西变内酉旨[2,3-di(4,-hydroxy-3' - methoxybenzyl) -2-buten-4-〇lide]中之至少一種以上之(1)至(6)中任一 者之組成物。 (1 0 )抗壞血酸脂肪酸酯為含有抗壞血酸棕櫚酸酯、或抗 壞血酸硬脂酸S旨之任一者之1種以上的(1 )至(9 )中任一者 之組成物。 · (1 1 )將抗壞血酸或抗壞血酸脂肪酸酯以對高度不飽和 脂肪酸、其鹽、或其酯之可溶解量以上的過剩量添加之(1 ) 至(1 0 )中任一者之組成物。 (1 2 )將過剩量之抗壞血酸以粉末或固形物添加之(1 1 ) 的外用組成物。 10 312/發明說明書(補件)/93-02/92132690 200417595 (1 3 )以更進一步添加維生素 E為特徵之(1 )至(1 2 )中任 一者之組成物。 (1 4 )含有(1 )至(1 3 )中任一者的組成物之食品。 (1 5 )含有(1 )至(1 3 )中任一者的組成物之粉末油脂。 (1 6 )含有(1 )至(1 3 )中任一者的組成物之幼兒用奶粉。 (1 7 )含有(1 )至(1 3 )中任一者的組成物之健康食品。 (發明效果) 含有具氧化安定性低的活性亞曱基之雙鍵、或末端之雙 鍵的有機物(尤其是高度不飽和脂肪酸)的組成物之氧化安 定性可大幅地提高。對過去受到限制的醫藥品、化妝品、 食品等可容易地添加含有高度不飽和脂肪酸之組成物,且 可增加添加量。由於本發明中所使用之芝麻抗氧化成分、 抗壞血酸或抗壞血酸脂肪酸酯皆為長期使用於食品上的物 質,故於利用在食品的情況,亦可提供安全的抗氧化劑。 【實施方式】 於本發明中作為對象物之具有雙鍵之有機物,係指即使 保存在室溫下也會自動地氧化之容易氧化的有機物。例 如,具有活性亞甲基之雙鍵、或具有末端之雙鍵的有機物, 可例示如不飽和脂質、高分子原料(單體)等。於不飽和脂 質中,尤以具有4個以上的雙鍵之高度不飽和脂肪酸特別 容易氧化,以傳統的抗氧化劑無法充分地抑制其氧化。 本發明中之作為對象物之高度不飽和脂肪酸或其酯,為 高度不飽和脂肪酸、高度不飽和脂肪酸的低級烷基的酯、 含有高度不飽和脂肪酸作為構成成分之三酸甘油酯等。具 11 312/發明說明書(補件)/93-02/92132690 200417595 體而言,可例示出:含有大量的二十碳五稀酸、二十二碳 六烤酸等之魚油等之水產動物油,與其酯化而成之二十碳 五烯酸乙基酯、二十二碳六烯酸乙基酯等。又,所謂之高 度不飽和脂肪酸,係指不飽和度為3以上的脂肪酸。尤其 以不飽和度4以上的脂肪酸之效果較為顯著。作為不飽和 度3以上的高度不飽和脂肪酸,可例示出:α -蘇子油酸、 花生酸、二十碳五稀酸、二十二碳六婦酸等。又,本發明 之高度不飽和脂肪酸類,包含該等脂肪酸的曱基酯、乙基 酯、三酸甘油酯、二酸甘油酯、單酸甘油酯等之酯型衍生 物。 二十碳五烯酸,係指碳數2 0之具有5個雙鍵的不飽和 脂肪酸的總稱,天然物之雙鍵的位置為5、8、1 1、1 4、1 7, 皆為順式(c i s )型的直鏈5價不飽和η - 3系脂肪酸。二十二 碳六烯酸,則為在4、7、1 0、1 3、1 6、1 9之位置具有雙鍵 之碳數2 2的直鏈六烯酸。此等之天然物來源的E P A、D Η A, 係以其本身或其甘油酯等之衍生物含有於天然油脂(尤其 是鮪魚、經魚、青花魚、沙丁魚、鳕魚等水產物油脂)中。 本發明中,只要是含有上述不飽和度3以上的高度不飽 和脂肪酸之油脂原料皆可使用。所謂「含有高度不飽和脂 肪酸之油脂原料」,可用沙丁魚、青花魚、秋刀魚、鮪魚、 鰹魚等之海產魚,微生物來源之脂質,磷蝦(k r i 1 1 )、蝦等 之曱殼類,魚油,動植物油,基因取代體植物油等作為原 料。 可將含有上述不飽和度3以上之高度不飽和脂肪酸的油 12 312/發明說明書(補件)/93-02/92132690 200417595 脂,經由冷;東(w i n t e r i n g )處理、酵素處理等濃縮高 和脂肪酸。或使含有上述不飽和度3以上的高度不 肪酸的油脂作成為脂肪酸或與醇的酯化體,施行 理、尿素加成處理、管柱(c ο 1 u m η )處理、酵素處理 界二氧化碳處理等,對高度不飽和脂肪酸進行濃縮 由於本發明之抗氧化劑並非將已經氧化者還原者 添加抗氧化劑之前,作為具有雙鍵之有機物,必須 化物經除去的狀態者。高度不飽和脂肪酸、其鹽、 的情況,必須進行脫膠、脫氧、脫色、脫臭等之處 成為氧化物經除去的狀態,精製的程度宜為 3.0meg/kg以下,AV為1.0以下,且於感官上為無 佳。 本發明之抗氧化劑,由於並無將經氧化者還原的 故添加之有機物以儘可能已將氧化物除去之精製度 佳。由於因氧化而發生的味道僅經由些微的氧化 生,故必須使用於添加抗氧化劑之前已充分精製者 製魚油的情況,宜使用P V 3 . 0 m e g / k g以下,A V 1 . 0 且精製成感官上無味者為佳。 以本發明之組成物中所含有之對象之一的不飽 酸作為構成成分的油脂之氧化腐敗,有起因於其水 起因於氧化者。隨著氧化而風味變差,係起因於氧 生的過氧化氫之分解生成物,故,例如,由大豆油 可得到丙醛、2 -戊烯醛(2 - p e n t e n a 1 )、己醛、乙醛 稀8签等。魚油之所以有不悅的味道,係起因於其中 312/發明說明書(補件)/93-02/92132690 度不飽 飽和脂 蒸餾處 、超臨 〇 ,故於 使用氧 或其酯 理,作 PV 為 味者為 作用, 高者為 即會發 。於精 以下, 和脂肪 解者與 化所產 的氧化 、2-丁 之高度 13 200417595 不飽和脂肪酸的氧化,經由氧化而發生特有的腥臭味。於 含有不飽和脂肪酸之魚油、大豆油、亞麻仁油、油菜籽油 等之精製油中,即使於氧化的最初期也會產生不愉悦的味 道,並發生顏色的劣化。此現象稱為油雜現象 (r e v e r s i ο η )。脫色植物精製油的顏色之油雜現象,據認為 係維生素Ε的氧化生成物、苯并二氫派喃-5,6 -醌所致者。 本發明為用以抑制不飽和脂肪酸的此等氧化者,於氧化安 定性低的動物油中尤其可看到顯著的效果。 作為本發明之對象之具有雙鍵之有機物的其他例子,可 例示出以具有雙鍵之高分子作為基材成分而使用之含有醫 藥品之布膠(t a p e s )與敷劑(c a t a ρ 1 a s m )、傷口綷創膏等。 因此,本發明可使用丁二烯橡膠、苯乙烯丁二烯橡膠、丁 基橡膠、氯丁二烯橡膠、丙烯酸橡膠、天然橡膠、異戊二 烯橡膠、苯乙烯異戊二烯苯乙烯嵌段共聚合物等之橡膠系 高分子。於此等橡膠系高分子中亦可併用通常所使用之抗 氧化劑。 作為本發明中所用之芝麻的抗氧化成分,可使用芝麻中 所含有之酚型之各種抗氧化物質。具體而言,可例示出·· 芝麻酚、芝麻明酚、表芝麻明酚、松脂醇、表松脂醇、紫 丁香樹脂酚、芝麻脂素、芝麻林酚、2,3 -二(4 '-羥基-3 ' -曱氧辛基)- 2-丁稀-4- 經酸内酯[2,3 - di(4'- hydroxy- 3, -m e t hoxy ben z y 1 ) - 2 - bu t e η - 4 一 ο 1 i d e ]等。由於圖 6 的 HPLC 之圖的波峰係使用電化學檢測器所檢測得之波峰,故分別 表示各抗氧化成分。如其所示般,於芝麻中含有大量的抗 14 312/發明說明書(補件)/93-02/92132690 200417595 氧化成分。芝麻酚等單獨使 使用此等之混合物,則可得 芝麻的抗氧化成分可單獨使 因而,本發明中所用之芝 麻而高度精製者,亦可為含 化成分與芝麻來源的物質、 者。或者為化學合成者亦可 只要芝麻油特有的味道不造 具體而言,可自芝麻種子 芝麻脫脂渣來萃取上述抗氧 蒸顧出的成分的渣(s c u m )而 度考量,以焙煎之芝麻為佳 一定的抗氧化成分,故亦可 況,以對作為主成份之中性 非極性溶劑除去為佳。芝麻 脂質的絕對量較多,抗氧化 到限制。 作為本發明之芝麻的萃取 Η P L C圖的波峰所示之抗氧化 溶劑、脂質、乳化劑所萃取 芝麻、芝麻油或芝麻渣,藉 曱乙酮、甘油、醋酸乙酯、 二氯曱烧、1,1,1,2_四氟乙 碳、1 - 丁醇、2 - 丁醇、丁烷 用雖可顯示充分的效果,但若 到更強的抗氧化作用。此等之 用,亦可數種組合使用。 麻的抗氧化成分可為含有由芝 有輕度精製的芝麻酚等之抗氧 芝麻木S分素類、維生素Ε類等 。再者,芝麻油亦可直接使用, 成問題即可。 、芝麻油或將芝麻油搾乾後的 化成分。亦可由芝麻油脫臭時 得到。由抗氧化成分增加之角 ,但由於未焙煎的芝麻亦含有 使用。由芝麻種子來萃取的情 脂質進行壓榨,或以己烷等之 油雖亦可直接使用,但其中性 成分的比例變少,故其用途受 物,只要是可萃取出圖 6的 成分的方法,無論是使用何種 者皆可使用。具體而言,可將 由一氧化二氮、丙S同、乙醇、 醋酸曱酯、二乙醚、環己烷、 烷、1,1,2 -三氯乙烯、二氧化 、1 -丙醇、2 -丙醇、丙烧、丙 312/發明說明書(補件)/93-02/92132690 15 200417595 二醇、己烷、甲醇等之有機溶劑;或三酸甘油酯、二 油酯、單酸甘油s旨、食用油脂等的脂質;丙二醇脂肪酸 聚甘油脂肪酸酯、山梨糖醇酐脂肪酸酯等之乳化劑萃 得到。再者,於溶劑蒸餾除去後,再度溶解到有機溶 之中,藉由分配到水中將水溶性成分除去,以過濾將 性成分除去等的操作,可將抗氧化成分濃縮。 本發明中,抗氧化劑的添加量可依保存條件、保存 而增減。芝麻的抗氧化劑的添加量,於芝麻酚的情況 高度不飽和脂肪酸添加 0 . 5 %以上則有效果。又以添力 以上為佳。雖對於抗壞血酸脂肪酸酯的高度不飽和脂 之可溶解量有0 . 1 %左右之限度,藉由過剩地添加可提 氧化作用的持續性,故可依目的而適當地增加。例如 精製魚油添加芝麻酚 1 . 0 %、抗壞血酸棕櫚酸酯 0. 1 % 況,即使於常溫開放之條件下亦可保存2〜3個月。 本發明中所用的抗壞血酸或抗壞血酸脂肪酸酯,可 抗壞血酸、抗壞血酸棕櫚酸酯、抗壞血酸硬脂酸酯等 壞血酸脂肪酸酯。此等之外,亦可使用抗壞血酸的鹽 而以對脂質的溶解性高者為佳。 本發明之抗氧化劑之中,經由使用較可溶解量多的 量之抗壞血酸或抗壞血酸脂肪酸酯,可更提高抗氧化 的持續性。於對油脂添加抗氧化劑時若不能溶解則 義,就此等考量,並未進行飽和濃度以上的添加,但 施例1 1〜1 2所示般,本發明之抗氧化劑中,藉由過剩 添加抗壞血酸或抗壞血酸脂肪酸酯,較添加飽和濃度 3 !2/發明說明書(補件)/93-02/92132690 酸甘 m ^ 取而 劑等 不溶 期間 ,對 ^ 1 % 肪酸 南抗 ,對 的情 使用 之抗 等, 過剩 作用 無意 如實 量地 的情 16 200417595 況,抗氧化作用可更持續。於芝麻的抗氧化成分的添加量 為相同,只將抗壞血酸或抗壞血酸脂肪酸酯予以過剩量地 添加即有效果。過剩量的抗壞血酸或抗壞血酸脂肪酸酯, 不論為粉末狀或固態之任一者皆有效。於不易自然擴散的 條件下使用時,以作成為微粉末狀均勻地分散為佳。 本發明中,於芝麻的抗氧化成分與抗壞血酸或抗壞血酸 脂肪酸酯之外,亦可再併用維生素E。維生素E可為α 、 /? 、7 5 -維生素Ε,或混合(m i X)維生素Ε之任一者, 但以5 -維生素E為佳。精製魚油之類的高度不飽和脂肪酸 或其鹽或酯等,於製造階段添加入維生素E者已大量市售 著。若以其作為原料,則自然地即含有維生素E。維生素E 之有無並不會影響到芝麻的抗氧化成分與抗壞血酸或抗壞 血酸脂肪酸酯的相乘效果。 藉由添加此芝麻的抗氧化成分及抗壞血酸或抗壞血酸 脂肪酸酯以提高氧化安定性的油脂,其單獨之氧化安定性 即相當優異,但亦可與其他的抗氧化劑併用。又,亦可與 氧化安定性優異的油脂(植物油脂等)混合使用。作為其他 的抗氧化劑,可舉出:異抗壞血酸、異抗壞血酸鈉、檸檬 酸異丙酯、二丁基羥基甲苯(BHT)、丁基羥基茴香醚(BHA) 等。作為用於食品的情況中可併用的抗氧化劑,可舉出: 食品添加劑中所記載之維生素E類、葵花萃取物、小紅豆 草本萃取物、土曲霉(aspergillusterreus)萃取物、伸乙 二胺四醋酸鈣二鈉、伸乙二胺四醋酸二鈉、鞣花酸(e 1 1 a g i c acid)、異抗壞血酸、異抗壞血酸鈉、槐(sophora japonica) 17 312/發明說明書(補件)/93-02/92132690 200417595 萃取物、r -谷維醇、兒茶酸、甘草油性萃取物、癒創木 (guaiac)脂、櫟精(quercetin)、檸檬酸異丙醋、丁香(clove) 萃取物、酵素處理異槲皮^(iso-quercitrin)、酵素處理 芸香苷(萃取物)、酵素分解蘋果萃取物、芝麻油未皂化物、 米糠油萃取物、米糠酵素分解物、L -半胱胺酸鹽酸鹽、二 丁基羥基曱苯、食用美人蕉萃取物、精油除去大苗香(anise) 萃取物、辣根(horseradish)萃取物、芝麻謎素 (sesamolin)、鼠尾草(sage)萃取物、芽菜萃取物、蕎麥草 本萃取物、單糖·胺基酸複合物、茶萃取物、天貝(tempe) 萃取物、蕺菜萃取物、菜籽油萃取物、生咖啡豆萃取物、 去甲二氫癒創木酸(nordihydroguaiaretic acid)、向日蔡 種子萃取物、椒類果實(pimenta)萃取物、阿魏酸(ferulic acid)、丁基羥基茴香醚、葡萄子萃取物、藍莓葉萃取物、 蜂膠萃取物、樹蕨(tree fern)·銀杏萃取物、橙皮苷 (hesperetin) '胡椒萃取物、鳳仙花萃取物、五倍子酸、 五倍子酸丙酯、茶樹(melaleuca)精油、桑黃素(morin)、 山桃萃取物、桉樹葉萃取物、龍膽根萃取物、芸香苷酵素 分解物、芸香苷(萃取物)、迷迭香萃取物,與在國外認可 使用之硫代二丙酸、硫代二丙酸二硬脂酸酯、五倍子酸辛 酯、五倍子酸十二烷酯、第三級丁基氫醌等。 由於本發明之組成物的氧化安定性優異,故可添加於各 種食品中。例如,使脫脂奶粉、牛奶酪蛋白、牛奶蛋白質、 乳糖、寡糖、蔗糖、糊精等溶解混合於熱水中後,溶解入 維生素·礦物質類作成水相,對其添加本發明之油脂,以 18 312/發明說明書(補件)/93-02/92132690 200417595 均質混合機等進行混合,並以均質化機進行均質化。將得 到之乳化液以一般的方法進行殺菌、濃縮、噴霧乾燥,製 得調製奶粉。同樣地,用各種粉末化基劑,可將本發明之 組成物作成為粉末油脂。於添加到食品中的情況,依食品 的性質,可決定直接添加油脂,或作為粉末油脂而添加。 可添加於一般的食品中,亦可作為健康食品、作為膠囊· 錠劑而製成所謂的補充劑。 茲就本發明之詳細内容以實施例加以說明。但本發明並 非限定於此等實施例者。 於本實施例中,精製魚油、芝麻酚、抗壞血酸棕櫚酸酯、 抗壞血酸、6 -維生素E係使用下述者。 精製魚油(含有δ -維生素E 0 · 5重量%):日本水產(股) 製 D D 0 i 1 T y p e 3 (以鮪魚油作為原料,進行脫膠、脫氧、 脫臭等之精製,精製成過氧化物值為5 m e g / K g以下、酸值 為1以下、顏色為加德納色數3以下之精製魚油)。 精製魚油(不含5 -維生素E者):於曰本水產(股)製 D D Oil Type 3的製造過程中,在添加(5 -維生素E之前所取 樣者。 精製魚油(沙丁魚油):曰本水產(股)製 D D 0 i 1 T y p e 2 (以沙丁魚油為原料,進行脫膠、脫氧、脫臭等之精製, 精製成過氧化物值為5 m e g / K g以下、酸值為1以下、顏色 為加德納色數3以下之精製魚油。含有E P A 2 8重量%、D Η A 1 2重量%。含有5 -維生素E Ο . 5重量%)。 芝麻酚:拿卡萊特斯克(股)製芝麻酚(純度9 8 % ) 19 312/發明說明書(補件)/93-02/92132690 200417595 抗壞血酸棕櫚酸酯:三共食品(股)製抗壞血酸棕櫚酸 酯(純度9 5 %以上) 抗壞血酸:拿卡萊特斯克(股)製 L ( + )-抗壞血酸(純度 9 9. 5 % ) δ _維生素 E :和光純藥工業(股)製 D - 5 -維生素 E (純 度 9 0%) 二十碳五烯酸乙基酯:以沙丁魚油作為原料,經由以金 屬鈉作為觸媒之與乙醇的酯交換反應,作成為沙丁魚油乙 基酯,然後,經精密蒸餾精製成用HPLC測定之純度為99% 者。 α -維生素 Ε:和光純藥工業(股)製 (±)-α -維生素 Ε (純度9 8 % ) (實施例1 ) 〈芝麻酚+抗壞血酸棕櫚酸酯+ (5 -維生素Ε的效果之確認〉 對精製魚油(含有(5 -維生素 Ε 0 . 5重量% )分別添加下述 之抗氧化劑,調製成試樣。 •芝麻S分(1 . 0重量% ) +抗壞血酸栋摘酸S旨(0 · 0 1重量% ) •芝麻酚(1 . 0重量% )單獨 •抗壞血酸棕櫚酸酯(0 · 0 1重量% )單獨 將此等之試樣 3mL 裝入 30mL 的褐色瓶中,以隔膜 (s e p t u m )密栓後,於6 0 °C下保存,於2日後,就頂部(h e a d s p a c e )的氧濃度以氣相色層分析儀測定,算出油脂所吸收 (與油脂反應)的氧氣量。結果示如圖 1。可知:經由對精 製魚油併用芝麻酚與抗壞血酸棕櫚酸酯,氧的吸收量得到 20 3 Π/發明說明書(補件)/93-02/92132690 200417595 抑制,與單獨添加芝麻酚或抗壞血酸棕櫚酸酯者相比,精 製魚油的氧化安定性得到大幅提高。 (實施例2 ) 〈芝麻酚+抗壞血酸+ 5 -維生素E的效果之確認〉 對精製魚油(含有5 -維生素 E 0 . 5重量% )分別添加下述 之抗氧化劑,調製成試樣。 •芝麻酚(1 · 0重量% ) +抗壞血酸(0 · 0 1重量% ) •抗壞血酸(0 _ 0 1重量% )單獨 將此等之試樣 4 m L裝入3 0 m L的褐色瓶中,進行與實施 例1同樣的保存試驗。結果示如圖2。可知:經由對精製 魚油併用芝麻酚與抗壞血酸,氧的吸收量得到抑制,與單 獨添加抗壞血酸者相比,精製魚油的氧化安定性得到大幅 提高。 (實施例3 ) 〈芝麻酚、抗壞血酸棕櫚酸酯的使用量之依存性〉 對精製魚油(含有5 -維生素E 0. 5重量% )分別添加下述 比例之(5 -維生素E :芝麻酚:抗壞血酸棕櫚酸酯,調製成 試樣。 • 0 . 5 °/〇 : 0.5%: 0 . 0 5 % • 0 . 5 °/〇 : 0 . 5 % : 0 . 1 % • 0. 5 °/〇 : 1.0°/〇: 0.05% • 0.5%: 1.0%: 0.1% 對此等試樣進行與實施例 2同樣的保存試驗 1 1日。結 果如圖3所示。由此結果得知:經由增加添加至精製魚油 21 312/發明說明書(補件)/93-02/92132690 200417595 之芝麻酚、抗壞血酸棕櫚酸酯的量,氧的吸收量可得到抑 制,精製魚油的氧化安定性依存於使用量的增加而提高。 (實施例4 ) 〈芝麻酚+抗壞血酸棕櫚酸酯的效果之確認〉 對精製魚油(不含5 -維生素 E )添加作為抗氧化劑之芝 麻酚(1 · 0重量%) +抗壞血酸棕櫚酸酯(0 · 0 1重量% ),調製成 試樣。對此試樣進行與實施例1同樣的保存試驗。結果示 如圖4。得知:即使無維生素E,經由併用芝麻盼與抗壞血 酸棕櫚酸酯,亦可抑制氧的吸收,大幅提高精製魚油的氧 化安定性。 (實施例5 ) 〈芝麻油萃取物+抗壞血酸棕櫚酸酯(0 . 1 重量%)+ 5 -維生 素E的效果之確認〉 對濃芝麻油 8 . 2 3 g添加曱醇1 0 0 m 1,劇烈攪拌後,將甲 醇自曱醇層蒸餾除去,得到0 . 2 8 g的曱醇萃取物。針對此 曱醇萃取物中含有著芝麻酚之事實,以薄層色層分析進行 確認(薄層,默克公司 K i e s ο 1 g e 1 6 0 F 2 5 4 0 . 2 5 m m ;開展 溶劑,己烷:二乙醚:醋酸=7 0 : 3 0 : 1 ;發色試藥, 1,l-Diphenyl-2-picrylhydrazyl ,自由基)。 對精製魚油(含有(5 -維生素 E 0 . 5重量% )分別添加下述 抗氧化劑,調製成試樣。 •上述芝麻油之曱醇萃取物(2 . 0 重量% ) +抗壞血酸棕櫊 酸酯(0 . 1重量% ) •上述芝麻油之曱醇萃取物(2. 0重量% )單獨 22 312/發明說明書(補件)/93-02/92132690 200417595 •抗壞血酸棕櫚酸酯(ο · 1重量%)單獨 對此等之試樣進行與實施例2同樣的保存試驗。結 如圖 5。得知:芝麻油之甲醇萃取物與芝麻酚相同, 獨添加時並無效果,經由與抗壞血酸棕櫚酸酯併用則 制氧的吸收量,使精製魚油的氧化安定性提高。 (實施例6 ) 〈焙煎芝麻渣萃取物+抗壞血酸棕櫚酸酯+ 6 -維生素E 果之確認〉 (1 )焙煎芝麻渣萃取物1 對焙煎芝麻渣1 . 0 k g添加乙醇2 . 0 k g,於4 0 °C下進 小時的劇烈攪拌,然後,將焙煎芝麻渣過濾,得到萃取 對經過濾的焙煎芝麻渣再度添加9 5 %乙醇1 . 5 k g,在 下進行1小時的劇烈攪拌、過濾,得到萃取液。將得 2次份的萃取液濃縮後,加入醋酸乙酯 2 4 0 g、水8 0 g 4 5 °C下劇烈攪拌1小時。攪拌後,將水層除去,對醋 酯層加入丙二醇單油酸酯 4 0 g,蒸餾除去醋酸乙酯, 5 8 g 之焙煎芝麻渣萃取物 1 (由於含有丙二醇單油 4 0 g,故實質上焙煎芝麻渣萃取物為1 8 g )。 (2 )焙煎芝麻渣萃取物2 對焙煎芝麻渣1 . 0 k g添加乙醇2 . 0 k g,於4 0 °C下進 小時的劇烈攪拌,然後,將焙煎芝麻渣過濾,得到萃取 對經過濾·的培煎芝麻渣再度添加9 5 %乙醇1 . 5 k g,在 下進行1小時的劇烈攪拌、過濾,得到萃取液。於得 2次份的萃取液中加入丙二醇單油酸酯4 0 g,將9 5 %乙 312/發明說明書(補件)/93-02/92132690 果示 於單 可抑 的效 行2 液。 4 0〇C 到之 ,在 酸乙 得到 酸酯 行2 液。 4 0°C 到之 醇蒸 23 200417595 餾除去,得到5 0 g之焙煎芝麻渣萃取物(由於含有丙二醇單 油酸酯4 0 g,故實質上焙煎芝麻渣萃取物為1 0 g )。 (3 )焙煎芝麻渣萃取物3 對焙煎芝麻渣2 0 0 g添加9 5 %之乙醇3 0 0 m 1,於4 0 °C下進 行2小時的劇烈攪拌,然後,將焙煎芝麻渣過濾,得到萃 取液。對經過濾的焙煎芝麻渣再度添加9 5 %乙醇3 0 0 m 1,在 4 0 °C下進行2小時的劇烈攪拌、過濾,得到萃取液。將得 到之 2 次份的萃取液濃縮後,加入醋酸乙酯 150ml、水 5 0ml,在室溫下劇烈攪拌1小時。攪拌後,將水層除去, 再蒸餾除去醋酸乙酯,得到9 . 0 g之焙煎芝麻渣萃取物。 對芝麻渣萃取物1藉由使用電化學檢測器之高效液相層 析儀進行測定。測定條件如下述。得到之圖示如圖 6。由 於是電化學檢測器的波峰,故全部的波峰皆為具有抗氧化 作用者。顯示出其含有芝麻酚、松脂醇等之多種的抗氧化 成分。 測定條件: 管柱:TSK-gel ODS-80Ts 4.6x 150mm 溶離液: Ο - 5 分 曱醇:水(含有 2 % 1 Μ 醋酸銨緩衝液, ρ Η 4 . 4 ) - 4 0 : 6 0 1 0 - 1 7 分 甲醇:水(含有 2 % 1 Μ 醋酸銨緩衝液, pH4.4)=70 : 30 2 2 - 4 0 分 曱醇:水(含有 2 °/〇 1 Μ 醋酸銨緩衝液, pH4. 4)-1 00 : 0 24 312/發明說明書(補件)/93-02/92132690 200417595 流速:1 . 0 m L /分 管柱溫度:3 5 t:
試樣濃度:1 Ο - 1 2 m g / m L 試樣溶解液:曱醇:乙醇:己烷=5 : 4 : 1
注入量:1 0 // L
電極1 (還原電位):-1 V
電極2(氧化電位):500mV
範圍:2 0 // A 對精製魚油(含有5 -維生素 E 0 . 5重量% )分別添加下述 的抗氧化劑,調製成樣品。 •上述焙煎芝麻渣萃取物 1 ( 1 . 0重量% ) +抗壞血酸棕橺 酸酯(0.05重量%) •上述焙煎芝麻渣萃取物 1 ( 1 . 0重量% ) +抗壞血酸棕櫚 酸酯(0 . 1重量% ) •上述焙煎芝麻渣萃取物1 (1 · 0重量%)單獨 •抗壞血酸棕櫚酸酯(0 · 1重量%)單獨 •上述焙煎芝麻渣萃取物 2 ( 1 . 0重量% ) +抗壞血酸棕櫚 酸酯(0 . 1重量% ) •上述焙煎芝麻渣萃取物 3 ( 1 . 0重量% ) +抗壞血酸棕櫚 酸酯(0 · 1重量°/〇) 對此等試樣進行與實施例2同樣的保存試驗。結果示如 圖 7。得知:此等焙煎芝麻渣萃取物也與芝麻酚相同,經 由與抗壞血酸棕櫚酸酯併用而可抑制氧的吸收量,使精製 魚油的氧化安定性提高。 25 312/發明說明書(補件)/93-02/92132690 200417595 (實施例7 ) 〈焙煎芝麻渣萃取物+抗壞血酸棕櫚酸酯+ 5 -維生素E的效 果之確認〉 對添加有實施例6的焙煎芝麻渣萃取物1 ( 1 . 0重量%) + 抗壞血酸棕櫚酸酯(0 · 1重量%)的試樣,及添加有焙煎芝麻 渣萃取物2 ( 1 . 0重量% ) +抗壞血酸棕搁酸酯(0 . 1重量% )的 試樣各1 0 g裝入褐色瓶中,於6 0 °C下進行開放式保存,對 保存中之丙二醛、烯醛類濃度的變化,使用Saftest公司 的S a f T e s t進行測定。結果示如圖8、圖9。得知:經由對 精製魚油添加焙煎芝麻渣萃取物及抗壞血酸棕櫊酸酯,魚 油的氧化分解物並為劣化魚油的臭味物質之丙二酸、稀酸 類的生成受到高度的抑制,使魚油安定化。 (實施例8 ) 實施例1的芝麻酚改為使用由焙煎芝麻渣萃取物3經由 石夕膠開放式管柱(silica gel open column)、0DS-HPLC 所 得之芝麻明酚,得到同樣的效果。 (實施例9 ) 實施例1的芝麻酚改為使用由焙煎芝麻渣萃取物3經由 矽膠開放式管柱、0DS-HPLC所得之松脂醇,得到同樣的效 果。 (實施例1 0 ) 實施例1的芝麻酚改為使用由焙煎芝麻渣萃取物3經由 矽膠開放式管柱、0DS-HPLC所得之 2,3-二(4'-羥基-3'-甲氧亨基)-2 - 丁稀-4 -經酸内S旨’得到同樣的效果。 26 312/發明說明書(補件)/93-02/92132690 200417595 (實施例1 1 ) 〈過剩量的抗壞血酸酯的效果之確認〉 對精製魚油(含有5 -維生素 E 0 . 5重量% )分別添加下述 之抗氧化劑,調製成試樣。 •芝麻酚(0 · 5 % ) +抗壞血酸棕櫚酸酯(0 · 1 % ) •芝麻酚(1 · 0 % ) +抗壞血酸棕櫚酸酯(0 . 1% ) 將此等之試樣 4 m L裝入3 0 m L的褐色瓶中,以隔膜密拴 後,於6 0 °C下保存,以氣相色層分析法測定保存中的氧濃 度,算出與油脂反應(被吸收)的氧氣量。又,就各抗氧化 劑的殘存量以使用電化學檢測器之HPLC進行分析。 結果分別示如圖 1 0、圖 1 1。不論在哪一情況中,皆顯 示抗壞血酸棕櫚酸酯先被消耗(氧化),一旦抗壞血酸棕櫊 酸酯消失,則精製魚油、3 -維生素E、芝麻酚即同時開始 進行氧化。因而,吾人認為,以6 -維生素E +芝麻酚+抗壞 血酸棕櫚酸酯作為抗氧化劑而存在的情況,抗壞血酸棕櫚 酸酯之殘存是重要的。為了確認此點,於與圖1 1同樣的系 統中,於第4日再追加抗壞血酸棕櫚酸酯0 . 1 %時的結果, 示如第1 2圖。於第1 1圖中,抗壞血酸棕櫚酸酯若消失, 則油脂即開始氧化(於第1 0日),而於同系統中在第4日追 加抗壞血酸棕櫚酸酯的第1 2圖中,油脂的氧化則於第1 0 曰以後亦仍受到抑制。 因此,由此等結果顯示:於本發明之抗氧化系統中,抗 壞血酸棕櫚酸酯的殘存是重要的。 (實施例1 2 ) 27 312/發明說明書(補件)/93-02/92132690 200417595 〈對於本發明之二十碳五烯酸乙基酯的效果,及 壞血酸棕櫊酸酯的效果之確認〉 對純度 9 9 %的二十碳五烯酸乙基酯(含有α 0 . 2 %)分別添加下述的抗氧化劑,調製成試樣。 •芝麻酚1 . 0 % +抗壞血酸棕櫚酸酯0 . Γ/〇 •芝麻酚1 . 0 % +抗壞血酸棕櫊酸酯0 . 5 % 將此等試樣保存於6 0 °C下,測定其過氧化物 結果示如圖 1 3。相較於添加溶解量的抗壞血1 (0 . 1 % )的情況,添加過剩量的抗壞血酸棕櫚酸 情況,其抗氧化作用較持續。 (實施例1 3 ) 〈與外用劑中一般所使用之抗氧化劑(第三級丁 (BHT))的比較> 就一般所使用的抗氧化劑之一的第三級丁 ; (Β Η T )與本發明之抗氧化配方做了比較。對精繁 魚油)(含有5 -維生素Ε 0· 5%)添加ΒΗΤ0· 5°/〇、1. 或添加芝麻酚1 . 0 %、抗壞血酸棕櫊酸酯0. 5 %。 油脂 4ML裝入30mL的褐色瓶中,以隔膜密栓 3 7 °C下,隨著時間經過以氣相色層分析儀測定 氧濃度,算出與油脂反應(經吸收者)的氧量。 (結果) Β Η T及本發明之抗氧化配方的抗氧化效果之 圖1 4。相較於與本發明之抗氧化配方所含的抗 總和為同量(1 · 5 % )的添加Β Η Τ之試樣,甚至相 312/發明說明書(補件)/93-02/92132690 過剩量的抗 -維生素 Ε 值(PV)。 酸棕櫊酸酯 酉旨(0 · 5 % )的 基羥基甲苯 基羥基甲苯 L魚油(沙丁 5 %、1 0 · 0 %, 將各樣品的 後,保存於 頂部空間的 比較,示如 氧化劑量的 較於廢倒性 28 200417595 地大量(1 0 · 0 % )地添加Β Η T之試料,本抗氧化配方顯示出較 高的抗氧化效果。 (產業上之可利用性) 依據本發明,可提供遠較含有過去的高度不飽和脂肪酸 的油脂於氧化安定性更為優異的油脂。藉此,於以健康為 目的之添加高度不飽和脂肪酸至食品、醫藥品等之時,可 容易地製造與保存,並可增加所要添加的食品之種類、高 度不飽和脂肪酸的添加量。具體而言,可提供於以含有 E P A、D Ρ Α的精製魚油使用於健康食品等之情況所用之泛用 性高的精製魚油。 【圖式簡單說明】 圖1為顯示實施例1之油脂的氧吸收量之圖。 圖2為顯示實施例2之油脂的氧吸收量之圖。 圖3為顯示實施例3之油脂的氧吸收量之圖。 圖4為顯示實施例4之油脂的氧吸收量之圖。 圖5為顯示實施例5之油脂的氧吸收量之圖。 圖6為實施例6之芝麻渣萃取物1之使用電化學檢測器 之高效液相層析儀的圖。 圖 7 為顯示實施例 6之樣品的氧吸收量之變化情形的 圖。 圖8為顯示實施例7之樣品的丙二酸(m a 1 ο n d i a 1 d e h y d e ) 濃度之變化情形的圖。 圖9為實施例 7之樣品的烯醛U 1 k e n a 1 )類濃度之變化 情形的圖。 29 312/發明說明書(補件)/93-02/92132690 200417595 圖1 0為顯不貫施例8之樣品(芝麻S分0 . 5 % )的氧吸收重 與抗氧化劑的殘存量之變化情形的圖。 圖1 1為顯示實施例8之樣品(芝麻酚1 . 0 % )的氧吸收量 與抗氧化劑的殘存量之變化情形的圖。 圖1 2為顯示實施例 8於之4日後追加抗壞血酸棕橺酸 酯的情況之樣品的氧吸收量與抗氧化劑的殘存量之變化情 形的圖。 圖1 3為顯示實施例9的樣品之P V的變化情形之圖。 圖1 4為顯示 Β Η T及本發明之抗氧化配方的抗氧化效果 的比較之圖面。 30 312/發明說明書(補件)/93-02/92132690
Claims (1)
- 200417595 拾、申請專利範圍: 1.有氧化安定性之含有具雙鍵之有機物的組成物,其特 徵在於,係添加有作為抗氧化劑之芝麻的抗氧化成分及抗 壞血酸或抗壞血酸脂肪酸酯。 2 .如申請專利範圍第1項之組成物,其中,雙鍵為具有 活性亞曱基(m e ΐ h y 1 e n e )的雙鍵或末端的雙鍵。 3. 如申請專利範圍第1項之組成物,其中,具有雙鍵之 有機物為高度不飽和脂肪酸、其鹽、或其酯。 4. 如申請專利範圍第1項之組成物,其中,具有雙鍵之 有機物為含有以高度不飽和脂肪酸作為構成成分之三酸甘 油酯或高度不飽和脂肪酸的低級醇酯。 5. 如申請專利範圍第1項之組成物,其中,具有雙鍵之 有機物為含有二十碳五稀酸、二十二碳六烤酸之任一者 1 種以上的脂肪酸、其鹽、或其酯。 6. 如申請專利範圍第1項之組成物,其中,具有雙鍵之 有機物係含有以含有二十碳五烯酸、二十二碳六烯酸之任 一者1種以上的脂肪酸作為構成成分的三酸甘油酯或高度 不飽和脂肪酸的低級醇酯。 7. 如申請專利範圍第1項之組成物,其中,具有雙鍵之 有機物係作為精製魚油而含有之高度不飽和脂肪酸的酯。 8. 如申請專利範圍第1項之組成物,其中,芝麻的抗氧 化成分係含有可經由用電化學檢測器之高效液相層析儀 (Η P L C )檢測之溶出時間為在 2.66、 3.40、3.84、4.57、 4.98、 5.82、 7.00、 8.67、 9.84、 11.24、 12.29、 12.49、 31 312/發明說明書(補件)/93-02/92132690 200417595 13.36、14.04、14.32、14.74、15.22' 15.60、15.82、16.34、 16.98、18.10、18.43、3 4. 9 1分處顯示出波峰的成分之至 少一個以上。 9 .如申請專利範圍第1項之組成物,其中,芝麻的抗氧 化成分為芝麻、芝麻油或芝麻渣藉由溶劑、脂質、或乳化 劑之任一者的單獨或混合溶劑之萃取物。 1 0 .如申請專利範圍第1項之組成物,其中,芝麻的抗 氧化成分為含有選自芝麻酚、芝麻明酚(s e s a m i η ο 1 )、表芝 麻明酉分(episesaminol)、松月旨西ΐ (pinoresinol)、表松月旨西享 (epi-pinoresinol)、紫 丁香枝于月旨酉分(syringaresinol)、沙 敏(5811111!)、芝麻林8分(365311101';[11〇1)、2,3-二(4/_經基 -3'-甲氧辛基)-2-丁烯-4-羥酸内酯[2,3-(11(4/-hydroxy-3 7 - methoxybenzyl)-2-buten-4-olide]中之至 少一種以上者。 1 1 .如申請專利範圍第 1項之組成物,其中,抗壞血酸 脂肪酸酯為含有抗壞血酸棕櫚酸酯、或抗壞血酸硬脂酸酯 之任一者之1種以上。 1 2.如申請專利範圍第 1項之組成物,其中,將抗壞血 酸或抗壞血酸脂肪酸酯以對高度不飽和脂肪酸、其鹽、或 其酯之可溶解量以上的過剩量添加。 1 3.如申請專利範圍第1項之組成物,其中,將抗壞血 酸或抗壞血酸脂肪酸酯以對高度不飽和脂肪酸、其鹽、或 其酯之可溶解量以上的過剩量以粉末或固形物添加。 1 4.如申請專利範圍第1項之組成物,其中,更進一步 32 312/發明說明書(補件)/93-02/92132690 200417595 添加維生素E。 1 5.如申請專利範圍第1項之組成物,其中,該組成物 為食品。 1 6.如申請專利範圍第1項之組成物,其中,該組成物 為粉末油脂。 1 7.如申請專利範圍第1項之組成物,其中,該組成物 為幼兒用奶粉。 1 8.如申請專利範圍第1項之組成物,其中,該組成物 為健康食品。33 312/發明說明書(補件)/93-02/92132690
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002339906 | 2002-11-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200417595A true TW200417595A (en) | 2004-09-16 |
| TWI332978B TWI332978B (zh) | 2010-11-11 |
Family
ID=32375789
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092132691A TW200418957A (en) | 2002-11-22 | 2003-11-21 | Compositions for external use containing polyunsaturated fatty acids salts thereof or esters thereof and method of manufacturing the same |
| TW092132690A TW200417595A (en) | 2002-11-22 | 2003-11-21 | Composition containing organic substance having double bond with improved oxidation stability |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092132691A TW200418957A (en) | 2002-11-22 | 2003-11-21 | Compositions for external use containing polyunsaturated fatty acids salts thereof or esters thereof and method of manufacturing the same |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060289834A1 (zh) |
| EP (2) | EP1564278B1 (zh) |
| JP (2) | JP4424743B2 (zh) |
| KR (3) | KR20050083960A (zh) |
| CN (2) | CN100352889C (zh) |
| AU (2) | AU2003284633B2 (zh) |
| CA (1) | CA2506611A1 (zh) |
| NZ (1) | NZ540154A (zh) |
| TW (2) | TW200418957A (zh) |
| WO (2) | WO2004048497A1 (zh) |
| ZA (1) | ZA200504059B (zh) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| JP2006282650A (ja) * | 2005-03-31 | 2006-10-19 | Sunstar Inc | 皮膚化粧料 |
| WO2007009591A1 (en) | 2005-07-18 | 2007-01-25 | Dsm Ip Assets B.V. | Method for rejuvenating aged food oils |
| ITMI20051718A1 (it) * | 2005-09-16 | 2007-03-17 | Betafarma S P A | Composizioni igieniche e cosmetiche per il trattamento delle dermatiti atopiche |
| BRPI0504797B1 (pt) * | 2005-10-27 | 2020-02-04 | Pele Nova Biotecnologia S.A. | formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação |
| JPWO2007132688A1 (ja) * | 2006-05-15 | 2009-09-24 | 日本水産株式会社 | 酸化が抑制された魚粉及びその製造方法 |
| US9107396B2 (en) | 2006-09-07 | 2015-08-18 | Oms Investments, Inc. | Stabilized synthetic brood pheromone and race-specific ratios of components for manipulating the behavior and physiology of honey bees |
| US7727517B2 (en) * | 2006-09-07 | 2010-06-01 | Contech Enterprises Inc. | Stabilized brood pheromone for manipulating the behavior and physiology of honey bees |
| US20080069942A1 (en) * | 2006-09-15 | 2008-03-20 | Glenn Roy Pizzey | Flax-stabilized fatty acid compositions and methods |
| ES2316275B1 (es) * | 2007-03-16 | 2010-03-22 | Universidad Politecnica De Madrid | Proceso de sustitucion de las grasas saturadas de la leche por aceites vegetales no hidrogenados. |
| WO2009070859A1 (en) * | 2007-12-04 | 2009-06-11 | Glanbia Nutritionals (Canada) Inc. | Flax-stabilized fatty acid compositions and methods |
| US20110236476A1 (en) | 2008-09-02 | 2011-09-29 | Amarin Corporation Plc. | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| PT3037089T (pt) | 2009-02-10 | 2020-03-04 | Amarin Pharmaceuticals Ie Ltd | Ester etílico de ácido eicosapentaenoico para tratamento de hipertrigliceridemia |
| WO2010127099A2 (en) | 2009-04-29 | 2010-11-04 | Amarin Corporation Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| SG10201605794PA (en) * | 2009-04-29 | 2016-09-29 | Amarin Pharmaceuticals Ie Ltd | Stable Pharmaceutical Composition And Methods Of Using Same |
| AU2014203034B2 (en) * | 2009-04-29 | 2016-09-15 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| CN108096209A (zh) | 2009-06-15 | 2018-06-01 | 阿马里纳制药公司 | 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法 |
| RU2012116169A (ru) | 2009-09-22 | 2013-10-27 | Сарджент'С Пет Кэа Продактс, Инк. | Пестицидная композиция, наносимая точечно |
| USRE45894E1 (en) | 2009-09-22 | 2016-02-23 | Sergeant's Pet Care Products, Inc. | Spot-on pesticide composition |
| US8614244B2 (en) | 2009-09-22 | 2013-12-24 | Segeant's Pet Care Products, Inc. | Spot-on pesticide composition |
| WO2011038122A1 (en) | 2009-09-23 | 2011-03-31 | Amarin Corporation Plc | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| RU2606853C2 (ru) * | 2010-03-04 | 2017-01-10 | Амарин Фармасьютикалз Айрлэнд Лимитед (Апил) | Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания |
| EP2366766B8 (en) | 2010-03-09 | 2017-04-19 | Stepan Specialty Products, LLC | Method of treating an edible oil and oil thus obtained |
| US9259590B2 (en) | 2010-03-17 | 2016-02-16 | Industry-Academic Cooperation Foundation Gyeongsang National University | Tube-structured battery to be inserted into living body |
| AU2011300428B2 (en) | 2010-09-07 | 2016-03-24 | Dsm Nutritional Products Ag | Comestible emulsions |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| EP2646013A4 (en) | 2010-11-29 | 2014-03-26 | Amarin Pharma Inc | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| JP2013001666A (ja) * | 2011-06-14 | 2013-01-07 | Yasuharu Omura | 栄養剤組成物 |
| EP2762129B1 (en) * | 2011-09-29 | 2019-08-07 | The Nisshin OilliO Group, Ltd. | Cosmetic composition and cosmetic |
| WO2013044294A1 (en) * | 2011-09-29 | 2013-04-04 | P.Guinane Pty Ltd | Animal feed composition |
| PH12014500972A1 (en) | 2011-11-01 | 2014-06-09 | Dsm Ip Assets Bv | Oxidatively stable polyunsaturated fatty acid containing oil |
| EP2775837A4 (en) | 2011-11-07 | 2015-10-28 | Amarin Pharmaceuticals Ie Ltd | METHODS OF TREATING HYPERTRIGLYCERIDEMIA |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| JP6307442B2 (ja) | 2012-01-06 | 2018-04-04 | アマリン ファーマシューティカルス アイルランド リミテッド | 対象の高感度(hs−crp)のレベルを低下させる組成物および方法 |
| ES2605823T3 (es) * | 2012-01-23 | 2017-03-16 | Restorsea, Llc | Cosmético |
| JP5312712B1 (ja) * | 2012-02-15 | 2013-10-09 | 株式会社明治 | 乳飲料及びその製造方法 |
| EP2858496B9 (en) | 2012-05-10 | 2023-11-29 | Solutex NA LLC | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors |
| SMT202500326T1 (it) | 2012-06-29 | 2025-11-10 | Amarin Pharmaceuticals Ie Ltd | Estere etilico dell’acido eicosapentaenoico per l’uso nella riduzione del rischio di ictus non fatale in un soggetto in terapia con statine |
| US8673325B1 (en) * | 2012-09-06 | 2014-03-18 | Dignity Sciences Limited | Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same |
| US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
| US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| CN103149311B (zh) * | 2013-01-30 | 2015-01-21 | 福建中烟工业有限责任公司 | 一种烟用香精香料中芝麻酚含量的测定方法 |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
| US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
| US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| CN104222319B (zh) * | 2013-06-21 | 2020-09-18 | 丰益(上海)生物技术研发中心有限公司 | 一种含芝麻素的油脂组合物 |
| JP6238190B2 (ja) * | 2013-07-04 | 2017-11-29 | 公立大学法人大阪市立大学 | コラーゲン産生促進用、エラスチン産生促進用および/またはケラチノサイト遊走促進用組成物 |
| US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| CN103627522A (zh) * | 2013-11-14 | 2014-03-12 | 浙江大学城市学院 | 灵芝孢子油纯天然复合抗氧化剂及提高其稳定性的方法 |
| AU2014361780B2 (en) | 2013-12-13 | 2016-11-24 | Restorsea, Llc | Exfoliative hair retention-promoting formulation |
| CN104739763B (zh) * | 2013-12-31 | 2018-12-11 | 健康元药业集团股份有限公司 | 一种具有抗炎和抗血栓形成作用的静脉注射用脂肪乳剂及其制备方法和用途 |
| EP3092904B1 (en) * | 2014-01-08 | 2020-01-08 | Cj Cheiljedang Corporation | Sesame oil and method for preparing same |
| JP2017515861A (ja) | 2014-05-16 | 2017-06-15 | レスターシー エルエルシイRestorsea, Llc | 二相性化粧品 |
| EP3151825B1 (en) | 2014-06-04 | 2020-03-25 | DS Biopharma Limited | Pharmaceutical compositions comprising dgla and use of same |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
| CN104450809B (zh) * | 2014-11-20 | 2017-09-29 | 武汉华士特工业生物技术开发有限公司 | 一种促进裂殖壶菌油脂中dha合成的方法 |
| EP3236783B1 (en) * | 2014-12-23 | 2020-02-05 | Evonik Operations GmbH | Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids |
| CN104593149A (zh) * | 2015-01-23 | 2015-05-06 | 河北科技师范学院 | 含有芝麻酚和芝麻酚酯的油脂抗氧剂组合 |
| HK1250345A1 (zh) | 2015-05-13 | 2018-12-14 | Afimmune Limited | 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法 |
| CN108025181A (zh) | 2015-07-21 | 2018-05-11 | 艾菲穆恩有限公司 | 用于治疗或预防癌症和神经疾病的包括15-hepe的组合物 |
| US10653703B2 (en) | 2015-09-03 | 2020-05-19 | Solutex Na Llc | Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same |
| MX394051B (es) | 2015-12-18 | 2025-03-24 | Afimmune Ltd | Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos de uso del mismo |
| US20200347300A1 (en) * | 2016-03-02 | 2020-11-05 | Fuji Oil Holdings Inc. | Fat or oil composition exhibiting anti-oxidation properties |
| MY193218A (en) | 2016-03-02 | 2022-09-26 | Fuji Oil Holdings Inc | Chocolate-like food containing polyunsaturated fatty acid |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| KR102036138B1 (ko) * | 2016-12-06 | 2019-10-24 | 한국식품연구원 | 비가열 참깨박 추출물을 유효성분으로 포함하는 항염증 조성물 |
| WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| WO2019042685A1 (en) | 2017-08-30 | 2019-03-07 | Unilever N.V. | COMPOSITION FOR PERSONAL CARE |
| CN107439899A (zh) * | 2017-09-01 | 2017-12-08 | 苏州农业职业技术学院 | 一种含有芝麻素的食品用抗氧化剂组合物及具有其的食品 |
| CN107603734A (zh) * | 2017-09-01 | 2018-01-19 | 苏州农业职业技术学院 | 一种天然抗氧化剂增强食用油抗氧化效果的方法 |
| CN107541340A (zh) * | 2017-09-01 | 2018-01-05 | 苏州农业职业技术学院 | 一种食用油用天然抗氧化剂及其应用 |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| KR102084415B1 (ko) * | 2018-06-04 | 2020-03-04 | 코스맥스 주식회사 | 에피피노레시놀을 포함하는 화장료 조성물 |
| KR102151044B1 (ko) * | 2018-07-03 | 2020-10-15 | 제이준코스메틱 주식회사 | 화장료 조성물 및 이의 제조방법 |
| EP3700518A4 (en) | 2018-09-24 | 2020-12-16 | Amarin Pharmaceuticals Ireland Limited | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT |
| JP2020150822A (ja) * | 2019-03-19 | 2020-09-24 | 三菱ケミカルフーズ株式会社 | 油脂、油脂の製造方法、および油脂用酸化抑制剤 |
| CN114980973A (zh) | 2019-11-12 | 2022-08-30 | 阿马里纳药物爱尔兰有限公司 | 降低心房纤颤和/或心房扑动受试者心血管事件风险的方法 |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| JP7473960B2 (ja) * | 2020-08-05 | 2024-04-24 | 横浜油脂工業株式会社 | 高度不飽和脂肪酸含有水溶性製剤 |
| CN112574146B (zh) * | 2020-12-17 | 2022-08-30 | 自然资源部第三海洋研究所 | 丁烯酸内酯类化合物复合纳米晶体的制备方法 |
| CN113061487A (zh) * | 2021-03-10 | 2021-07-02 | 烟台市万船口海洋生物科技有限公司 | 一种鱼油生产工艺 |
| EP4326244A4 (en) | 2021-04-21 | 2025-03-19 | Amarin Pharmaceuticals Ireland Limited | METHODS TO REDUCE THE RISK OF HEART FAILURE |
| CN115414269A (zh) * | 2022-08-03 | 2022-12-02 | 陕西畅想制药有限公司 | 含芝麻酚的化妆品用超分子溶液及其制备方法与应用 |
| CN115444033B (zh) * | 2022-09-22 | 2025-01-24 | 黑龙江飞鹤乳业有限公司 | 复配抗氧化剂及乳粉中氧化风味物质的测定方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5910505A (ja) * | 1982-07-07 | 1984-01-20 | Nisshin Oil Mills Ltd:The | 油状美白化粧料 |
| WO1984002271A1 (en) * | 1982-12-09 | 1984-06-21 | Hafsten Raymond J Jr | Readily-absorpable fatty acid emulsions |
| IT1223290B (it) * | 1987-07-27 | 1990-09-19 | Indena Spa | Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche |
| JPH01202278A (ja) * | 1988-02-05 | 1989-08-15 | Nisshin Oil Mills Ltd:The | 食品用品質保持剤 |
| JPH02189394A (ja) * | 1989-01-19 | 1990-07-25 | Tsukishima Shokuhin Kogyo Kk | 油脂組成物 |
| NL9201438A (nl) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen. |
| JPH06298642A (ja) * | 1993-04-14 | 1994-10-25 | Japan Tobacco Inc | 高度不飽和脂肪酸含有o/w型乳剤及びその酸化防止方法 |
| GB2280449B (en) * | 1993-07-02 | 1996-10-02 | Charleville Res | A method for preparing an edible water-in-oil emulsion |
| GB9321479D0 (en) * | 1993-10-18 | 1993-12-08 | Scotia Holdings Plc | Stabilisation of polyunsaturates |
| DE4341000A1 (de) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen |
| JP3689137B2 (ja) * | 1994-08-19 | 2005-08-31 | 俊之 渡辺 | アレルギー性皮膚疾患治療用外用剤 |
| JP4062639B2 (ja) * | 1996-12-23 | 2008-03-19 | 日本水産株式会社 | 皮膚外用剤 |
| FR2758458B1 (fr) * | 1997-01-21 | 2000-01-07 | Jean Noel Thorel | Produits cosmetiques ou dermo-pharmaceutiques respectant l'ecologie cutanee |
| US6426078B1 (en) * | 1997-03-17 | 2002-07-30 | Roche Vitamins Inc. | Oil in water microemulsion |
| US20010031275A1 (en) * | 1998-02-09 | 2001-10-18 | Forse R Armour | Sesamol inhibitor of delta-5-desaturase activity and uses therefor |
| JPH11269456A (ja) * | 1998-03-19 | 1999-10-05 | Suntory Ltd | 高度不飽和脂肪酸組成物 |
| KR100292828B1 (ko) | 1998-08-01 | 2001-06-15 | 장인순 | 위생적, 영양적으로 안전한 분쇄육 제품 |
| KR20000025783A (ko) * | 1998-10-14 | 2000-05-06 | 김성년 | 항산화제를 첨가하여 방사선 조사에 의한 고지방질 가공식품의산패를 억제하는 방법 |
| US6048891A (en) * | 1998-12-17 | 2000-04-11 | Loma Linda University Medical Center | Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease |
| DE60013130T2 (de) * | 1999-06-23 | 2005-01-05 | Forbes Medi-Tech Inc., Vancouver | Konjugate von ascorbinsäure und phytosterolen oder phytostanolen und ihre verwendung zur behandlung von gefässkrankheiten |
| US6235331B1 (en) * | 1999-07-29 | 2001-05-22 | Nisshin Flour Milling Co Ltd | Modified fish oil type material containing highly unsaturated fatty acid and/or esters thereof, and a composition containing said material |
| US6384247B2 (en) * | 2000-06-19 | 2002-05-07 | Daicel Chemical Industries, Ltd. | Method of producing sesamol formic acid ester and sesamol |
| ITMI20010129A1 (it) * | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
-
2003
- 2003-11-21 US US10/536,013 patent/US20060289834A1/en not_active Abandoned
- 2003-11-21 TW TW092132691A patent/TW200418957A/zh unknown
- 2003-11-21 NZ NZ540154A patent/NZ540154A/en not_active IP Right Cessation
- 2003-11-21 CN CNB2003801039403A patent/CN100352889C/zh not_active Expired - Fee Related
- 2003-11-21 EP EP03774122.0A patent/EP1564278B1/en not_active Expired - Lifetime
- 2003-11-21 JP JP2004554998A patent/JP4424743B2/ja not_active Expired - Lifetime
- 2003-11-21 TW TW092132690A patent/TW200417595A/zh not_active IP Right Cessation
- 2003-11-21 AU AU2003284633A patent/AU2003284633B2/en not_active Ceased
- 2003-11-21 KR KR1020057009245A patent/KR20050083960A/ko not_active Ceased
- 2003-11-21 WO PCT/JP2003/014905 patent/WO2004048497A1/ja not_active Ceased
- 2003-11-21 KR KR1020057008827A patent/KR101045035B1/ko not_active Expired - Fee Related
- 2003-11-21 CN CNB2003801039367A patent/CN100348184C/zh not_active Expired - Fee Related
- 2003-11-21 US US10/535,413 patent/US8722104B2/en active Active
- 2003-11-21 AU AU2003284617A patent/AU2003284617A1/en not_active Abandoned
- 2003-11-21 WO PCT/JP2003/014877 patent/WO2004048496A1/ja not_active Ceased
- 2003-11-21 ZA ZA200504059A patent/ZA200504059B/en unknown
- 2003-11-21 CA CA002506611A patent/CA2506611A1/en not_active Abandoned
- 2003-11-21 EP EP03774145A patent/EP1571195A4/en not_active Withdrawn
- 2003-11-21 KR KR1020117009013A patent/KR20110053281A/ko not_active Withdrawn
- 2003-11-21 JP JP2004555005A patent/JPWO2004048497A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN100348184C (zh) | 2007-11-14 |
| EP1571195A1 (en) | 2005-09-07 |
| EP1571195A4 (en) | 2009-08-26 |
| AU2003284633A1 (en) | 2004-06-18 |
| KR20050072144A (ko) | 2005-07-08 |
| US20060134178A1 (en) | 2006-06-22 |
| AU2003284633B2 (en) | 2008-07-10 |
| WO2004048496A1 (ja) | 2004-06-10 |
| CN100352889C (zh) | 2007-12-05 |
| KR20110053281A (ko) | 2011-05-19 |
| KR20050083960A (ko) | 2005-08-26 |
| CN1714136A (zh) | 2005-12-28 |
| AU2003284617A1 (en) | 2004-06-18 |
| ZA200504059B (en) | 2007-12-27 |
| KR101045035B1 (ko) | 2011-06-30 |
| US20060289834A1 (en) | 2006-12-28 |
| CN1714135A (zh) | 2005-12-28 |
| CA2506611A1 (en) | 2004-06-10 |
| NZ540154A (en) | 2008-07-31 |
| JPWO2004048496A1 (ja) | 2006-03-23 |
| EP1564278A1 (en) | 2005-08-17 |
| JPWO2004048497A1 (ja) | 2006-03-30 |
| EP1564278A4 (en) | 2009-04-22 |
| WO2004048497A1 (ja) | 2004-06-10 |
| JP4424743B2 (ja) | 2010-03-03 |
| TW200418957A (en) | 2004-10-01 |
| EP1564278B1 (en) | 2018-01-10 |
| TWI332978B (zh) | 2010-11-11 |
| US8722104B2 (en) | 2014-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200417595A (en) | Composition containing organic substance having double bond with improved oxidation stability | |
| KR100918891B1 (ko) | 크립테코디늄 속으로 부터의 항산화 추출물의 생산 및 용도 | |
| US9301536B2 (en) | Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract | |
| WO2004052115A1 (en) | Glyceride compositions and methods of making and using same | |
| US20120219647A1 (en) | Antioxidant composition | |
| US9145534B2 (en) | Fat containing composition | |
| TWI778199B (zh) | Dha富集的多不飽和脂肪酸組合物 | |
| JP2009225724A (ja) | アラキドン酸類含有組成物 | |
| US20070128292A1 (en) | Novel nutraceutical and pharmaceutical compositions and their uses | |
| Mendoza | Enrichment of vegetable oils with phenolic antioxidants for food applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |